The invention relates to a novel cyanoacrylate medical adhesive and preparation method and application thereof, the main components of the medical adhesive is composed of alkyl cyanoacrylate and/or alkoxv cyanoacrylate and lactyl cyanoacrylate, and by adding a novel stabilizer system, the stability of the novel cyanoacrylate medical adhesive product in the invention increases substantially, the product can be stored and transported at room temperature, degradation performance of the product was greatly improved, the main technical indicators of product such as curing time and mechanical properties can meet the clinical needs, and the user experience of the product such as adhesive film flexibility is greatly improved, so the cyanoacry late medical adhesive is an widely used surgical hemostatic materials.

The invention relates to a novel cyanoacrylate medical adhesive and preparation method and application thereof, the main components of the medical adhesive is composed of alkyl cyanoacrylate and/or alkoxv cyanoacrylate and lactyl cyanoacrylate, and by adding a novel stabilizer system, the stability of the novel cyanoacrylate medical adhesive product in the invention increases substantially, the product can be stored and transported at room temperature, degradation performance of the product was greatly improved, the main technical indicators of product such as curing time and mechanical properties can meet the clinical needs, and the user experience of the product such as adhesive film flexibility is greatly improved, so the cyanoacry late medical adhesive is an widely used surgical hemostatic materials.

A hydrogel-based biological delivery vehicle used to effectively deliver drug and biological material to tissue or organ sites. More specifically, a hydrogel binding matrix having a biopolymer backbone containing carboxyl groups. Tyramine may be substituted for at least a portion of the carboxyl groups, so that, when hydrogen peroxide is added, it causes creation of covalent bonds between tyramine molecules and cross-links the hydrogel binding matrix, thereby enabling the hydrogel binding matrix to transition from liquid to gel state. The hydrogel binding matrix, in its liquid form, is capable of encapsulating drug reservoirs to create a homogenous liquid with evenly distributed particles containing drugs or target molecules. As the hydrogel binding matrix solidifies into a gel state, the newly created cross-links do not disrupt or react with the drugs or target molecules contained within the drug reservoirs. This hydrogel-based biological delivery vehicle can be used in several medical applications.

A hydrogel-based biological delivery vehicle used to effectively deliver drug and biological material to tissue or organ sites. More specifically, a hydrogel binding matrix having a biopolymer backbone containing carboxyl groups. Tyramine may be substituted for at least a portion of the carboxyl groups, so that, when hydrogen peroxide is added, it causes creation of covalent bonds between tyramine molecules and cross-links the hydrogel binding matrix, thereby enabling the hydrogel binding matrix to transition from liquid to gel state. The hydrogel binding matrix, in its liquid form, is capable of encapsulating drug reservoirs to create a homogenous liquid with evenly distributed particles containing drugs or target molecules. As the hydrogel binding matrix solidifies into a gel state, the newly created cross-links do not disrupt or react with the drugs or target molecules contained within the drug reservoirs. This hydrogel-based biological delivery vehicle can be used in several medical applications.

An embodiment includes a wound dressing comprising: a shape memory polymer (SMP) foam, including open cells, having first and second states; and a hydrogel (HG) included within the cells; wherein (a) in a first position a composite, including the SMP foam and the HG, is configured to be located proximate a hemorrhagic tissue with the SMP foam in the first state; (b) in a second position the composite is configured to be expanded to the second state against the hemorrhagic tissue when the SMP foam is plasticized at 37 C. depressing a glass transition temperature (T.sub.g) of the SMP foam to below 25 C. Other embodiments are described herein.

An embodiment includes a wound dressing comprising: a shape memory polymer (SMP) foam, including open cells, having first and second states; and a hydrogel (HG) included within the cells; wherein (a) in a first position a composite, including the SMP foam and the HG, is configured to be located proximate a hemorrhagic tissue with the SMP foam in the first state; (b) in a second position the composite is configured to be expanded to the second state against the hemorrhagic tissue when the SMP foam is plasticized at 37 C. depressing a glass transition temperature (T.sub.g) of the SMP foam to below 25 C. Other embodiments are described herein.

A skin compatible component attachable to mammalian skin. The component is formed as a silicone matrix comprising a polyorganosiloxane derived silicone polymer and moisture control particulate distributed within the polymer network being configured to absorb moisture from the skin. The skin compatible component may be utilised as an ostomy wafer or flange to secure an ostomy appliance to the skin and in particular peri-skin.

A kit and a bioadhesive, comprising gelatin, alginate, montmorillonite and a coupling agent, which is characterized by rapid curing, optimal viscosity, high burst strength, flexibility, biocompatibility and biodegradability, is disclosed.

A kit and a bioadhesive, comprising gelatin, alginate, montmorillonite and a coupling agent, which is characterized by rapid curing, optimal viscosity, high burst strength, flexibility, biocompatibility and biodegradability, is disclosed.

An embodiment includes a wound dressing comprising: a shape memory polymer (SMP) foam, including open cells, having first and second states; and a hydrogel (HG) included within the cells; wherein (a) in a first position a composite, including the SMP foam and the HG, is configured to be located proximate a hemorrhagic tissue with the SMP foam in the first state; (b) in a second position the composite is configured to be expanded to the second state against the hemorrhagic tissue when the SMP foam is plasticized at 37? C. depressing a glass transition temperature (T.sub.g) of the SMP foam to below 25? C. Other embodiments are described herein.